Search

Search Results

• 

  Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

  Dimitris Rigopoulos, Aikaterini Patsatsi, Christina Antoniou, Dimitrios Sotiriadis, Angeliki Roussaki-Schulze, Nadia Boubouchairopoulou, Ioannis Skiadas, Vasillios Tsekouras, Ana Cristina Hernandez Daly

  21-11-2022

  https://doi.org/10.4081/dr.2022.9265

  1387

  PDF: 355

  HTML: 20

• Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

  Edoardo Mortato, Silvia Baratta, Luca Rubino, Anna Paola De Caro, Francesco Loconsole

  19-06-2023

  https://doi.org/10.4081/dr.2023.9755

  713

  PDF: 322

  HTML: 9
• 

  Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

  Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  19-05-2023

  https://doi.org/10.4081/dr.2023.9692

  896

  PDF: 447

  HTML: 15
• 

  Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

  Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

  29-12-2022

  https://doi.org/10.4081/dr.2023.9613

  1592

  PDF: 425

  HTML: 70
• 

  Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study

  Hao Trong Nguyen, Long Dinh Hoang Vo, Nguyen Nhat Pham

  14-07-2022

  https://doi.org/10.4081/dr.2022.9516

  1405

  PDF: 573

  HTML: 15
• 

  Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

  Chuyen Thi Hong Nguyen, Oanh Phan Tram Nguyen

  21-11-2022

  https://doi.org/10.4081/dr.2022.9469

  1137

  PDF: 447

  HTML: 27

• A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

  Vinh Ngo Minh, Thiên Phúc Lý, Hao Nguyen Trong, Chuong Nguyen Hoang

  12-04-2024

  https://doi.org/10.4081/dr.2024.9899

  823

  PDF: 470

  HTML: 17

• HLA-Cw6 increases the risk of psoriasis and early onset before twenty-seven years of age among the Vietnamese population

  Nhi Thi Uyen Pham, Thuong Van Nguyen, Hao Trong Nguyen

  16-10-2023

  https://doi.org/10.4081/dr.2023.9854

  1005

  PDF: 407

  HTML: 19

• Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

  Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  12-11-2024

  https://doi.org/10.4081/dr.2024.10080

  840

  PDF: 368

• S-MAPA: bridging the gap in psoriasis severity assessment

  Trang Thi Thuy Vu, Chuyen Thi Hong Nguyen, Trung The Van

  28-05-2025

  https://doi.org/10.4081/dr.2025.10231

  113

  PDF: 52
• 

  Late reaction to ustekinumab infusion

  Marina Resener Morais, Luana Pizarro Meneghello, Carina Flores de Oliveira, André Vicente Esteves Carvalho

  e2

  09-09-2013

  https://doi.org/10.4081/dr.2013.e2

  3812

  PDF: 588

  HTML: 259
• 

  Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

  Nicoletta Bernardini, Nevena Skroza, Elisabeth Prevete, Federica Marraffa, Ilaria Proietti, Ersilia Tolino, Alessandra Mambrin, Giovanni Rossi, Salvatore Volpe, Giuseppe Bersani, Concetta Potenza

  23-11-2022

  https://doi.org/10.4081/dr.2022.9476

  1225

  PDF: 395

  HTML: 23
• 

  Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

  Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

  11-10-2017

  https://doi.org/10.4081/dr.2017.7079

  1218

  PDF: 575

  HTML: 137
• 

  Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

  Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

  21-11-2022

  https://doi.org/10.4081/dr.2022.9447

  1166

  PDF: 335

  HTML: 38
• 

  Erythrodermic psoriasis improved by tildrakizumab

  Giampaolo Trevisan, Lerica Germi, Luigi Naldi

  23-11-2022

  https://doi.org/10.4081/dr.2022.9448

  957

  PDF: 521

  HTML: 18
• 

  Successful treatment of severe psoriasis vulgaris in child with methotrexate injection

  Agatha Anindhita, S. Sawitri

  01-04-2019

  https://doi.org/10.4081/dr.2019.8096

  991

  PDF: 439

• A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

  Luciano Ibba, Luigi Gargiulo, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  06-06-2023

  https://doi.org/10.4081/dr.2023.9722

  632

  PDF: 361

  HTML: 11
• 

  Characteristics and decreased Vitiligo Area Scoring Index of vitiligo patients with narrowband-UVB phototherapy in Yogyakarta, Indonesia

  Nabila Kirtti Pradipta, Viensa Ryoto, Retno Danarti, Arief Budiyanto

  22-05-2023

  https://doi.org/10.4081/dr.2023.9708

  748

  PDF: 380

  HTML: 6
• 

  Bacterial colonization of psoriasis plaques. Is it relevant?

  Eva Marcus, Diana Demmler, Andreas Rudolph, Matthias Fischer

  e14

  05-08-2011

  https://doi.org/10.4081/dr.2011.e14

  1537

  PDF: 682

  HTML: 621

• Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

  Chuyen Thi Hong Nguyen, Liem Viet Quoc Tran

  27-11-2024

  https://doi.org/10.4081/dr.2024.10090

  413

  PDF: 174